Doctors Details

Dr. Sandip Ganguly
Senior Consultant17 Years of Experience
Medical Oncologist
Apollo Gleneagles Hospital, Kolkata
MBBS, MD, DM
Reg. No.:75102, West Bengal Medical Council
English
Get Free Evaluation
About Dr. Sandip Ganguly
- Dr. Sandip Ganguly is a renowned Medical Oncologist with over 15 years of experience.
- He specializes in treating breast cancer, cervical cancer, anal cancer, lung cancer, gastrointestinal cancer, thoracic cancer, gynecological cancer, etc. Â
- He earned his MBBS and MD in General Medicine from Kasturba Medical College, Mangalore, in 2008 and 2011.
- Â Later, in 2015, he specialized in cancer treatment by completing a DM in Medical Oncology from the Kidwai Memorial Institute of Oncology.
- He is deeply committed to patient care and actively participates in global clinical trials and research initiatives.
- Dr. Ganguly has numerous publications in esteemed medical journals and advocates passionately for patient assistance programs to ensure optimal cancer treatment outcomes.
Paper Published by Dr. Sandip Ganguly
He has published over 123 articles. Some of them are:
- Real-world study of safety and efficacy of erlotinib as second line and beyond in ALK-rearranged advanced non-small cell lung cancer patients in India – a multicentre chart review study (ROSELAND)
- Real-world survival outcomes and treatment patterns in patients (pts) with unresectable hepatocellular carcinoma (uHCC): Results from the OREIOS study.
- Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non-Small-Cell Lung Cancer: Results From the CANOPY-1 Trial
- LBA11 Amivantamab plus chemotherapy vs. chemotherapy among Asian patients with EGFR-mutant advanced NSCLC after progression on osimertinib: A MARIPOSA-2 subgroup analysis
- 287MO Real-world experience with maintenance PARP inhibitor plus minus bevacizumab in newly diagnosed advanced ovarian cancer with germline BRCA mutations or homologous recombination deficiency (HRD) positive
- Amivantamab plus chemotherapy with and without lapatinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study
- 272P Correlation of dihydropyrimidine dehydrogenase gene mutation with toxicity among gastrointestinal cancers (GI) taking 5-fluorouracil-based chemotherapy: Experience from a tertiary cancer center in the eastern part of India
- 272P Correlation of dihydropyrimidine dehydrogenase gene mutation with toxicity among gastrointestinal cancers (GI) taking 5-fluorouracil-based chemotherapy: Experience from a tertiary cancer center in the eastern part of India
- Pancreatic Adenocarcinoma with Primary Tumor Calcification and Calcified Liver Metastasis: Report of a Rare Case and Review of Literature
- Hypofractionated radiation therapy comparing a standard radiotherapy schedule (over three weeks) with a novel 1-week schedule in adjuvant breast cancer: An open-label randomized controlled study (HYPORT-Adjuvant) - Study protocol for a multicentre, randomized phase III trial
Experience of Dr. Sandip Ganguly
- Consultant Medical Oncologist Tata Medical Center - 2023
- Resident, Medical Oncology Kidwai Memorial Institute Of Oncology - 2015
- Senior Resident Kasturba Medical College, Mangalore - 2012
Education of Dr. Sandip Ganguly
- MBBS - Kasturba Medical College, Mangalore - 2008
- MD - Kasturba Medical College, Mangalore - 2011
- DM - Medical Oncology- Kidwai Memorial Institute of Oncology - 2015
Top Oncology Doctors in India
Delivering Quality Care, Trusted Globally